<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04112277</url>
  </required_header>
  <id_info>
    <org_study_id>2018-A03393-52</org_study_id>
    <nct_id>NCT04112277</nct_id>
  </id_info>
  <brief_title>Observational Prospective Study of Opiate-free Anesthesia for Anterior Total Hip Replacement</brief_title>
  <acronym>ASOPHA</acronym>
  <official_title>Observational Prospective Study of Opiate-free Anesthesia for Anterior Total Hip Replacement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hôpital Privé Sévigné</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hôpital Privé Sévigné</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Opioid-free anesthesia (ATO) is a multimodal anaesthesia combining different analgesic and&#xD;
      anesthetic modalities thus excluding opiates as an intraoperative. Recent studies have found&#xD;
      a benefit from the ATO on postoperative rehabilitation and reduced length of hospitalization.&#xD;
&#xD;
      Periarticular infiltration with a local anesthetic is one of the measures proposed in OFA&#xD;
      during the PTH.&#xD;
&#xD;
      PTH remains a painful procedure and the occurrence of morphinic-related side effects in&#xD;
      sometimes elderly patients is often observed.&#xD;
&#xD;
      The main objective of this study is to assess the feasibility of ATO in anterior hip&#xD;
      replacement under general anesthesia with the primary endpoint of morphine consumption&#xD;
      measured 24 hours after surgery.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1, 2019</start_date>
  <completion_date type="Actual">February 25, 2020</completion_date>
  <primary_completion_date type="Actual">February 25, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cumulative morphine consumption</measure>
    <time_frame>24 hours after the procedure</time_frame>
    <description>morphine equivalent [mg]</description>
  </primary_outcome>
  <enrollment type="Actual">100</enrollment>
  <condition>Rehabilitation</condition>
  <condition>Analgesia</condition>
  <condition>Anesthesia</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cumulative morphine consumption</intervention_name>
    <description>morphine equivalent [mg] 24 hours after the procedure</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with ASA (American Society of Anesthesiology) I-III for whom a total Hip&#xD;
        Prosthesis is programmed anteriorly (Hueler Method).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18 and 85&#xD;
&#xD;
          -  ASA (American Society of Anesthesiology) I-III&#xD;
&#xD;
          -  Total Hip Prosthesis programmed anteriorly&#xD;
&#xD;
          -  Prior obtaining free and informed written consent .Affiliation or beneficiary of a&#xD;
             social security scheme. Patients affiliated with or beneficiaries of a social security&#xD;
             plan and not included in another trial.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant women or breastfeeding Spinal anesthesia Patient on long-term opiate Body&#xD;
             Mass Index (BMI) - 20 or 45kg/m2 Incomprehension of the ENS scale Unaccompanied&#xD;
             cardiac conduction disorder, Adam-Stokes syndrome Preoperative Spontaneous Cardiac&#xD;
             Frequency - 40 beats/min Left ventricle ejection fraction - 40% Unpaired sleep apnea&#xD;
             syndrome (OSA) Adult incompetent, adults under guardianship or curatorial or deprived&#xD;
             of liberty Allergy to one of the protocol products or their excipients:&#xD;
             levobupivacaine, paracetamol, pregabalin, ketoprofen, dexmedetomidine&#xD;
             Paracetamol-specific contraindication: hepatocellular deficiency Ketoprofen-specific&#xD;
             contraindications: creatinine clearance - 60ml/min, ATCD of perforated peptic ulcer,&#xD;
             heart failure, progressive hemorrhage, asthma associated with ketoprofen use&#xD;
             Contraindications to nefopam: symptomatic prostate disorders, angle-closing glaucoma,&#xD;
             epilepsy Participation in another clinical study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hopital Privé Sévigné</name>
      <address>
        <city>Cesson-Sévigné</city>
        <zip>35510</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>September 30, 2019</study_first_submitted>
  <study_first_submitted_qc>October 1, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 2, 2019</study_first_posted>
  <last_update_submitted>February 25, 2020</last_update_submitted>
  <last_update_submitted_qc>February 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

